Royal Prince Alfred Hospital
🇦🇺Australia
Clinical Trials
75
Active:0
Completed:30
Trial Phases
5 Phases
Phase 1:3
Phase 2:3
Phase 3:6
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (73 trials with phase data)• Click on a phase to view related trials
Not Applicable
57 (78.1%)Phase 3
6 (8.2%)Phase 4
4 (5.5%)Phase 1
3 (4.1%)Phase 2
3 (4.1%)No trials found
News
Imugene's Azer-cel Achieves 75% Response Rate in Phase 1b Trial for Relapsed DLBCL
Imugene's azer-cel, an allogeneic off-the-shelf CAR T therapy, demonstrated a 75% overall response rate with 55% complete response rate in patients with relapsed/refractory diffuse large B-cell lymphoma who had failed multiple prior therapies.
Gene Therapy Breakthrough Effectively Cures 'Bubble Boy' Disease in Infants
A groundbreaking gene therapy developed by US scientists has effectively cured infants with X-linked severe combined immunodeficiency (X-SCID), a rare and fatal genetic disorder that leaves children without functioning immune systems.